Ube, Japan

Etsuro Itoh


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Etsuro Itoh – Innovator in Pyrrolopyridazine Derivatives

Introduction

Etsuro Itoh, an esteemed inventor based in Ube, Japan, has made significant contributions to the field of chemistry through his innovative work on pyrrolopyridazine derivatives. With a single patent to his name, Itoh showcases the potential of specialized compounds that can have impactful applications in various industries.

Latest Patents

Etsuro Itoh's notable patent involves pyrrolopyridazine derivatives characterized by a general formula that allows for a diverse range of chemical modifications. The formula outlines several variable groups including R¹, R², R³, R⁴, and R⁵, which can represent various alkenyl, alkynyl, aryl, and cycloalkyl configurations. This complexity marks a substantial advancement in chemical synthesis and provides avenues for further research and development in pharmaceuticals and materials science.

Career Highlights

Throughout his career, Etsuro Itoh has lent his expertise to renowned organizations, including Sankyo Company, Limited and Ube Industries, Inc. His work in these companies has helped to foster innovative approaches in the development of chemical compounds and enhance their applications.

Collaborations

Etsuro Itoh has collaborated with several talented individuals in the field, notably Tomio Kimura and Nobuhiko Shibakawa. These partnerships have contributed to the sharing of ideas, resources, and knowledge, leading to significant advancements in their respective areas of research.

Conclusion

Etsuro Itoh stands as a prominent figure in the realm of chemical innovation, specifically through his work on pyrrolopyridazine derivatives. His dedication to advancing the field, along with his collaborations and contributions to major companies, outlines a successful career driven by ingenuity and research excellence.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…